Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
VA Palo Alto Health Care System, Palo Alto, CA
mi
from
Palo Alto, CA
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
VA Palo Alto Health Care System, Palo Alto, CA
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
San Francisco VA Medical Center, San Francisco, CA
mi
from
San Francisco, CA
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
San Francisco VA Medical Center, San Francisco, CA
mi
from
San Francisco, CA
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
mi
from
West Los Angeles, CA
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
mi
from
West Los Angeles, CA
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Bay Pines VA Healthcare System, Pay Pines, FL
mi
from
Bay Pines, FL
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Bay Pines VA Healthcare System, Pay Pines, FL
mi
from
Bay Pines, FL
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
North Florida/South Georgia Veterans Health System, Gainesville, FL
mi
from
Gainesville, FL
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
North Florida/South Georgia Veterans Health System, Gainesville, FL
mi
from
Gainesville, FL
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Charlie Norwood VA Medical Center, Augusta, GA
mi
from
Augusta, GA
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Charlie Norwood VA Medical Center, Augusta, GA
mi
from
Augusta, GA
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Atlanta VA Medical and Rehab Center, Decatur, GA
mi
from
Decatur, GA
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Atlanta VA Medical and Rehab Center, Decatur, GA
mi
from
Decatur, GA
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Jesse Brown VA Medical Center, Chicago, IL
mi
from
Chicago, IL
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Jesse Brown VA Medical Center, Chicago, IL
mi
from
Chicago, IL
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Richard L. Roudebush VA Medical Center, Indianapolis, IN
mi
from
Indianapolis, IN
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Richard L. Roudebush VA Medical Center, Indianapolis, IN
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
VA Boston Healthcare System West Roxbury Campus, West Roxbury, MA
mi
from
West Roxbury, MA
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
VA Boston Healthcare System West Roxbury Campus, West Roxbury, MA
mi
from
West Roxbury, MA
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
VA Ann Arbor Healthcare System, Ann Arbor, MI
mi
from
Ann Arbor, MI
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
VA Ann Arbor Healthcare System, Ann Arbor, MI
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Minneapolis VA Health Care System, Minneapolis, MN
mi
from
Minneapolis, MN
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Minneapolis VA Health Care System, Minneapolis, MN
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Kansas City VA Medical Center, Kansas City, MO
mi
from
Kansas City, MO
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Kansas City VA Medical Center, Kansas City, MO
mi
from
Kansas City, MO
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
New Mexico VA Health Care System, Albuquerque, NM
mi
from
Albuquerque, NM
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
New Mexico VA Health Care System, Albuquerque, NM
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
VA Western New York Healthcare System, Buffalo, NY
mi
from
Buffalo, NY
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
VA Western New York Healthcare System, Buffalo, NY
mi
from
Buffalo, NY
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY
mi
from
New York, NY
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY
mi
from
New York, NY
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Durham VA Medical Center, Durham, NC
mi
from
Durham, NC
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Durham VA Medical Center, Durham, NC
mi
from
Durham, NC
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Cincinnati VA Medical Center, Cincinnati, OH
mi
from
Cincinnati, OH
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Cincinnati VA Medical Center, Cincinnati, OH
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Louis Stokes VA Medical Center, Cleveland, OH
mi
from
Cleveland, OH
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Louis Stokes VA Medical Center, Cleveland, OH
mi
from
Cleveland, OH
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Dayton VA Medical Center, Dayton, OH
mi
from
Dayton, OH
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Dayton VA Medical Center, Dayton, OH
mi
from
Dayton, OH
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Oklahoma City VA Medical Center, Oklahoma City, OK
mi
from
Oklahoma City, OK
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Oklahoma City VA Medical Center, Oklahoma City, OK
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Portland VA Medical Center, Portland, OR
mi
from
Portland, OR
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Portland VA Medical Center, Portland, OR
mi
from
Portland, OR
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
mi
from
Pittsburgh, PA
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Ralph H. Johnson VA Medical Center, Charleston, SC
mi
from
Charleston, SC
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Ralph H. Johnson VA Medical Center, Charleston, SC
mi
from
Charleston, SC
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Memphis VA Medical Center, Memphis, TN
mi
from
Memphis, TN
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Memphis VA Medical Center, Memphis, TN
mi
from
Memphis, TN
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
mi
from
Dallas, TX
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
mi
from
Dallas, TX
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Michael E. DeBakey VA Medical Center, Houston, TX
mi
from
Houston, TX
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Michael E. DeBakey VA Medical Center, Houston, TX
mi
from
Houston, TX
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
South Texas Health Care System, San Antonio, TX
mi
from
San Antonio, TX
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
South Texas Health Care System, San Antonio, TX
mi
from
San Antonio, TX
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
VA Salt Lake City Health Care System, Salt Lake City, UT
mi
from
Salt Lake City, UT
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
VA Salt Lake City Health Care System, Salt Lake City, UT
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Hunter Holmes McGuire VA Medical Center, Richmond, VA
mi
from
Richmond, VA
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Hunter Holmes McGuire VA Medical Center, Richmond, VA
mi
from
Richmond, VA
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Salem VA Medical Center, Salem, VA
mi
from
Salem, VA
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Salem VA Medical Center, Salem, VA
mi
from
Salem, VA
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
VA Puget Sound Health Care System Seattle Division, Seattle, WA
mi
from
Seattle, WA
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
VA Puget Sound Health Care System Seattle Division, Seattle, WA
mi
from
Seattle, WA
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
St. Louis VA Medical Center John Cochran Division, St. Louis, MO
mi
from
Saint Louis, MO
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
St. Louis VA Medical Center John Cochran Division, St. Louis, MO
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
Status: Enrolling
Updated:  12/31/1969
Ocular Oncology Service, Wills Eye Institute
mi
from
Philadelphia, PA
Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
Status: Enrolling
Updated: 12/31/1969
Ocular Oncology Service, Wills Eye Institute
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Palo Alto, CA
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
University of Colorado at Denver
mi
from
Denver, CO
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
University of Colorado at Denver
mi
from
Denver, CO
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
George Washington University
mi
from
Washington,
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
George Washington University
mi
from
Washington,
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve Univ
mi
from
Cleveland, OH
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
University of Pennsylvania
mi
from
Pittsburgh, PA
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
University of Pennsylvania
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
mi
from
Seattle, WA
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
Wake Forest University
mi
from
Winston-Salem, NC
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated:  12/31/1969
University of Pittsburg
mi
from
Pittsburgh, PA
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Status: Enrolling
Updated: 12/31/1969
University of Pittsburg
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Followed by an Open-Label Continuation Period to Assess the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Mission Viejo, CA
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Followed by an Open-Label Continuation Period to Assess the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Followed by an Open-Label Continuation Period to Assess the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Aurora, CO
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Followed by an Open-Label Continuation Period to Assess the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Followed by an Open-Label Continuation Period to Assess the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Cooper City, FL
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Followed by an Open-Label Continuation Period to Assess the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cooper City, FL
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Followed by an Open-Label Continuation Period to Assess the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Winter Park, FL
A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Followed by an Open-Label Continuation Period to Assess the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Winter Park, FL
Click here to add this to my saved trials